Martin Brenner
Vorstandsvorsitzender bei IBIO, INC.
Vermögen: 15 695 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Martin Brenner
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
22
| Public Company | Pharmaceuticals: Other | 22 |
| Public Company | Pharmaceuticals: Major | 20 | |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The private company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life.
19
| Subsidiary | Pharmaceuticals: Major | 19 |
16
| Subsidiary | Biotechnology | 16 |
| Public Company | Biotechnology | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Martin Brenner
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
| AMGEN INC. | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree Graduate Degree | |
| University of California, Davis | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree Doctorate Degree | |
| Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
| LIGAND PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | President General Counsel Chief Executive Officer President | |
| University of Virginia | College/University | Masters Business Admin Corporate Officer/Principal Undergraduate Degree | |
| University of Pennsylvania | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
Ligand UK Research Ltd.
 Ligand UK Research Ltd. Pharmaceuticals: MajorHealth Technology Part of Ligand Pharmaceuticals, Inc., Ligand UK Research Ltd. develops pharmaceutical products. The private company is based in London, UK. Founded in 1995. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| OMNIAB, INC. | Miscellaneous Commercial Services | Chief Executive Officer General Counsel Chairman | |
OmniAb Operations, Inc.
 OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | Biotechnology | Chief Executive Officer General Counsel Chairman | |
Ligand UK Group Ltd.
 Ligand UK Group Ltd. Financial ConglomeratesFinance Founded in 1995, Ligand UK Group Ltd. is a subsidiary of Ligand Pharmaceuticals, Inc. and functions as an investment holding private company. The company is based in Cambridge, UK. | Financial Conglomerates | Director/Board Member Director/Board Member Director/Board Member | |
| VERNALIS | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| Baylor College of Medicine | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | General Government | General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
| The Johns Hopkins University | College/University | Graduate Degree Graduate Degree Graduate Degree | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| INTEGRATED BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| European Round Table of Industrialists | Director/Board Member Corporate Officer/Principal | ||
| CSL LIMITED | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| VIELA BIO, INC. | Biotechnology | Director/Board Member General Counsel | |
| AB VOLVO | Trucks/Construction/Farm Machinery | Chief Executive Officer Chairman | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Chief Executive Officer Chairman | |
Lonza AG
 Lonza AG BiotechnologyHealth Technology Lonza AG engages in the research in as well as development, production, and distribution of chemical products and materials. The firm also carries out investment and lending transactions. The company was founded on December 7, 1897 and is headquartered in Visp, Switzerland. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Greenleaf Health Inc.
 Greenleaf Health Inc. Miscellaneous Commercial ServicesCommercial Services Part of Kinsale Holdings, Inc., Greenleaf Health Inc. is a leading FDA regulatory consulting firm that provides strategic and technical guidance to pharmaceutical, biotechnology, and medical device companies. The private company is based in Washington. Greenleaf is guided by experts with a combined total of more than 300 years of FDA experience, including former leaders throughout the agency. The American company was founded in 2007 by Patrick Ronan. Greenleaf Health was acquired by Kinsale Holdings, Inc. on April 19, 2021. | Miscellaneous Commercial Services | President Corporate Officer/Principal | |
| University of California San Diego | College/University | Undergraduate Degree Doctorate Degree | |
| Yale University | College/University | Undergraduate Degree Graduate Degree | |
Metabasis Therapeutics, Inc.
 Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Pharmaceuticals: Major | Corporate Secretary Chief Executive Officer | |
| The University of Texas at Austin | College/University | Undergraduate Degree Undergraduate Degree | |
iBio CDMO LLC
 iBio CDMO LLC BiotechnologyHealth Technology Part of iBio, Inc., iBio CDMO LLC is a private company that is advancing its immuno-oncology pipeline of antibody therapeutic candidates against hard-to-drug tumor targets. The company is based in Bryan, TX. The company uses its patented discovery platform, which leverages artificial intelligence to consistently deliver antibody candidates against difficult targets. The company's lead candidate, IBIO-101, stimulates anti-tumor immunity by selectively depleting immunosuppressive TREG cells while sparing tumor cell killing T-Effector cells. iBio is pioneering the next generation of antibody therapeutics, leveraging its artificial intelligence-based and epitope steered antibody discovery platform. The company seeks to partner IBIO-400 to develop a safe and effective subunit vaccine capable of differentiating infected from vaccinated animals. The CEO of the company is Thomas F. Isett. | Biotechnology | Chief Operating Officer Chief Executive Officer | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| University of the Witwatersrand | College/University | Doctorate Degree Doctorate Degree | |
| HOSPIRA, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| Center for Drug Evaluation & Research | General Government | Director/Board Member Corporate Officer/Principal | |
| Tufts University School of Medicine | College/University | Chief Tech/Sci/R&D Officer Doctorate Degree | |
Elucida Oncology, Inc.
 Elucida Oncology, Inc. BiotechnologyHealth Technology Elucida Oncology, Inc. operates as a biotechnology company which focuses on clinical research and development. The company was founded by Isaac Blech, Michelle Bradbury, Ulrich Weisner, and Steven Larson in 2014 and is headquartered in Monmouth Junction, NJ. | Biotechnology | Chairman Director/Board Member | |
| HIKMA PHARMACEUTICALS PLC | Pharmaceuticals: Generic | Chief Executive Officer Sales & Marketing | |
| Amherst College | College/University | Undergraduate Degree Undergraduate Degree | |
| ANAPTYSBIO, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
The United States Pharmacopeia
 The United States Pharmacopeia Pharmaceuticals: MajorHealth Technology The United States Pharmacopeia engages in manufacturing medicines. It offers dietary supplements, and foods. The company is headquartered in Rockville, MD. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Villanova University | College/University | Undergraduate Degree Undergraduate Degree | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member Corporate Officer/Principal |
Statistik
International
| Vereinigte Staaten | 38 |
| Vereinigtes Königreich | 7 |
| Schweden | 3 |
| Schweiz | 3 |
| Belgien | 2 |
Sektoral
| Health Technology | 27 |
| Consumer Services | 15 |
| Commercial Services | 6 |
| Government | 3 |
| Finance | 2 |
Operativ
| Director/Board Member | 306 |
| Corporate Officer/Principal | 229 |
| Independent Dir/Board Member | 102 |
| Chief Executive Officer | 77 |
| Undergraduate Degree | 62 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Magda Marquet | 30 |
| Iain Dukes | 30 |
| Dennis Fenton | 28 |
| Louis Schweitzer | 28 |
| Briggs Morrison | 26 |
| Geneviéve B. Berger | 23 |
| Jeremy S. Caldwell | 22 |
| Michele Hooper | 21 |
| Leif Valdemar Johansson | 21 |
| D. Gilliland | 20 |
| David Brennan | 19 |
| Pascal Soriot | 17 |
| Sigurdur Olafsson | 16 |
| Julie Brown | 15 |
| Michael Mendelsohn | 14 |
- Börse
- Insiders
- Martin Brenner
- Unternehmensverbindungen
